REGENERON Trademark

Trademark Overview


On Thursday, October 15, 2020, a trademark application was filed for REGENERON with the United States Patent and Trademark Office. The USPTO has given the REGENERON trademark a serial number of 90256467. The federal status of this trademark filing is REGISTERED as of Tuesday, October 12, 2021. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The REGENERON trademark is filed in the Pharmaceutical Products category with the following description:

Antivirals
regeneron

General Information


Serial Number90256467
Word MarkREGENERON
Filing DateThursday, October 15, 2020
Status700 - REGISTERED
Status DateTuesday, October 12, 2021
Registration Number6522241
Registration DateTuesday, October 12, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 26, 2021

Trademark Statements


Goods and ServicesAntivirals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 3, 2020
Primary Code005
First Use Anywhere DateMonday, May 31, 2021
First Use In Commerce DateMonday, May 31, 2021

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 12, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, September 8, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 7, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 26, 2021STATEMENT OF USE PROCESSING COMPLETE
Monday, August 23, 2021USE AMENDMENT FILED
Wednesday, August 25, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 23, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, March 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 26, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 22, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 22, 2020ASSIGNED TO EXAMINER
Thursday, December 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 19, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords


regeneron antivirals